238 related articles for article (PubMed ID: 17183885)
1. In vitro activity of azithromycin as an antipseudomonal agent.
Mahapatra A; Mahapatra A; Padhi S; Mahapatro S; Ghosh SK
Indian J Pathol Microbiol; 2006 Oct; 49(4):634-5. PubMed ID: 17183885
[No Abstract] [Full Text] [Related]
2. [Monitoring of antibiotic resistance in Ps. aeruginosa and in Ps. maltophilia in the Ospedale di Pordenone].
Chiaradia V; Santini GF
G Ital Chemioter; 1988; 35(1-3):23-5. PubMed ID: 3151487
[No Abstract] [Full Text] [Related]
3. Early Pseudomonas aeruginosa infection in individuals with cystic fibrosis: is susceptibility testing justified?
Macdonald D; Cuthbertson L; Doherty C; Campana S; Ravenni N; Taccetti G; Govan JR
J Antimicrob Chemother; 2010 Nov; 65(11):2373-5. PubMed ID: 20837573
[TBL] [Abstract][Full Text] [Related]
4. Five-year report of national surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolated from non-tertiary care hospitals in Korea (2002-2006).
Yoo J; Sohn ES; Chung GT; Lee EH; Lee KR; Park YK; Lee YS
Diagn Microbiol Infect Dis; 2008 Mar; 60(3):291-4. PubMed ID: 18068936
[TBL] [Abstract][Full Text] [Related]
5. Induction of resistance to fluoroquinolones in clinical and environmental isolates of Pseudomonas aeruginosa.
Prasad SV; Ballal M; Shivananda PG
Indian J Pathol Microbiol; 2007 Jan; 50(1):94-6. PubMed ID: 17474274
[TBL] [Abstract][Full Text] [Related]
6. [Pseudomonas: microbiological aspects and sensitivity to tobramycin and gentamycin].
Ceruti T; Bassi L; Biazzi E; Fasani AM; Pedroni P
Arch Sci Med (Torino); 1982; 139(4):463-5. PubMed ID: 6820271
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial activity of fosfomycin against multidrug-resistant Pseudomonas aeruginosa in vitro.
Kobayashi Y; Sumitani Y; Sugita K; Aikawa N
Int J Antimicrob Agents; 2007 Dec; 30(6):563-4. PubMed ID: 17900870
[No Abstract] [Full Text] [Related]
8. The effect of antimicrobial agents on Pseudomonas aeruginosa strains isolated from sporadical cases and nosocomial infections.
Meitert E; Sima F; Savulian C; Chersulick E; Petrescu AM
Arch Roum Pathol Exp Microbiol; 1988; 47(3-4):227-38. PubMed ID: 3150919
[No Abstract] [Full Text] [Related]
9. In-vitro bactericidal activity of colistin against biofilm-associated Pseudomonas aeruginosa and Acinetobacter baumannii.
Cai Y; Wang R; Liang BB; An MM
J Hosp Infect; 2009 Aug; 72(4):368-70. PubMed ID: 19443079
[No Abstract] [Full Text] [Related]
10. Re: Pseudomonas aeruginosa isolates from burn patients in the Northwest of Pakistan.
Arya SC; Agarwal N; Agarwal S
Burns; 2010 Aug; 36(5):739-40. PubMed ID: 20071094
[No Abstract] [Full Text] [Related]
11. [Effects of azithromycin on the virulence of Pseudomonas aeruginosa].
Reinert P
Pathol Biol (Paris); 1995 Jun; 43(6):551-3. PubMed ID: 8539081
[TBL] [Abstract][Full Text] [Related]
12. Routine susceptibility tests with ticarcillin and tobramycin in combination should be more appropriate than with each antibiotic alone in cystic fibrosis Pseudomonas aeruginosa.
Lapointe JR; Bourget C; Mainville S; Lafleur L; Lagacé J; Montplaisir S
J Chemother; 1989 Jul; 1(4 Suppl):184-6. PubMed ID: 16312360
[No Abstract] [Full Text] [Related]
13. Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.
Wolter DJ; Acquazzino D; Goering RV; Sammut P; Khalaf N; Hanson ND
Clin Infect Dis; 2008 Jun; 46(12):e137-41. PubMed ID: 18462098
[TBL] [Abstract][Full Text] [Related]
14. [Pseudomonas maltophilia infections].
Pintér M; Kántor M
Orv Hetil; 1974 Feb; 115(5):254-5. PubMed ID: 4839507
[No Abstract] [Full Text] [Related]
15. An in vitro investigation of levofloxacin and ciprofloxacin against clinical isolates of Pseudomonas aeruginosa.
Segatore B; Perilli M; Larosa M; Setacci D; Celenza G; Amicosante G
Int J Antimicrob Agents; 2007 Oct; 30(4):374-6. PubMed ID: 17659863
[No Abstract] [Full Text] [Related]
16. Current therapies for pseudomonas aeruginosa.
Giamarellou H; Kanellakopoulou K
Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
[TBL] [Abstract][Full Text] [Related]
17. Use of Etest to assess synergy of antibiotic combinations against clinical isolates of Pseudomonas spp.
Fodor E; Hajdú E; Nagy E
Int J Antimicrob Agents; 2005 Feb; 25(2):183-4. PubMed ID: 15664494
[No Abstract] [Full Text] [Related]
18. Outbreak of Pseudomonas aeruginosa producing IMP-9-type metallo-beta-lactamase in Guangzhou, China.
Chao Z; Xiao-Feng W; Dan-Hong S; Jin-Ping Y; Nan-Shan Z
Int J Antimicrob Agents; 2008 Oct; 32(4):363-5. PubMed ID: 18619819
[No Abstract] [Full Text] [Related]
19. First report of the carbapenem-resistant Pseudomonas aeruginosa producing IMP-7 metallo-beta-lactamase in Slovakia.
Ohlasova D; Kmet V; Niks M
Int J Antimicrob Agents; 2007 Oct; 30(4):370-1. PubMed ID: 17709230
[No Abstract] [Full Text] [Related]
20. Mutations in 23S rRNA confer resistance against azithromycin in Pseudomonas aeruginosa.
Marvig RL; Søndergaard MS; Damkiær S; Høiby N; Johansen HK; Molin S; Jelsbak L
Antimicrob Agents Chemother; 2012 Aug; 56(8):4519-21. PubMed ID: 22644032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
